WFI
HZNP

West Family Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

West Family Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,217
Closed -$233K – 325
2022
Q1 		$233K Buy
2,217
+244
+12% +$23.8K 0.07% 236
2021
Q4 		$213K Sell
1,973
-490
-20% -$53.5K 0.06% 289
2021
Q3 		$270K Buy
+2,463
New +$256K 0.07% 234

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

West Family Investments's HZNP Position: Q2 2022 in Review

West Family Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 2,217 shares — an estimated $233K sold.

West Family Investments first reported a position in HZNP in Q3 2021 and held it in 3 quarters. The position peaked at $270K in Q3 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

  • West Family Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • West Family Investments sold 2,217 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $233K.
  • West Family Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • West Family Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $270K in Q3 2021.
  • 616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on West Family Investments's 13F filing for Q2 2022, filed 12 Aug 2022.